CE approved

Artiplus

ArtiPlus - Line Illustration

We developed a new foldable iris fixated Phakic IOL for the correction of presbyopia. Or as we call it; Artiplus. The use of our CTF technology results in amazing first patient outcomes which makes us very confident about this new lens. In november 2024 the Artiplus is CE approved and available in Europe, South Korea and Argentina.

Natural vision at all distances​
The multi-segmented optic with CTF technology offer a smooth transition from far to near between the segments. This transition offers a constant defocus between the two sharp focal points, delivering excellent intermediate vision. 
 
Reducing Glare & Halos
The use of segments instead of concentric rings reduce photic phenomena thereby helping patients to adapt more naturally to their new vision. 

Based on trusted Artiflex platform
Artiflex has proven to be one of the world’s safest, most effective IOL designs. 

Discover all specs

 

Publications

Artiplus: A New Path for Young Presbyopes

At the private Artiplus Expert Panel event during ESCRS 2024 in Barcelona, Spain, a select group of refractive surgeons gathered to explore Ophtec’s latest innovation—Artiplus.

Read Article
Ophtec’s Artiplus Shows Promising One-Year Clinical Results

At the invite-only Artiplus Experts Panel during ESCRS 2024 in Barcelona, the unveiling of one-year clinical trial outcomes for the Artiplus iris-fixated multifocal phakic intraocular lens sparked significant interest among the esteemed refractive surgeons in attendance.

Read article
Clinical evedince

We have compiled a clear overview of the clinical evidence of the Artiplus. You can download these below.

Download now

Receive more information

Talk to sales

Ophtec works closely with ophthalmologists and medical staff. Contact one of our experts for tailored advice in your area.

View all global offices